ТРОМБОФИЛИЯ ПРИ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХ: ФАКТОРЫ И РИСКИ
Ключевые слова:
тромбофилия, факторы, риски, хроническая обструктивная болезнь легких, инфаркт миокарда.Аннотация
В статье выделены факторы, имеющие значение в развитии гиперкоагуляционных состояний у больных хронической обструктивной болезнью легких (ХОБЛ), что может открыть новые возможности для профилактики тромбофилических осложнений у больных ХОБЛ. В статье анализируются теоретические аспекты и систематизируются исследования, посвященные изучению различных факторов и основных звеньев нарушений гемостаза в клинической практике среди данной группы пациентов.
Библиографические ссылки
Abbate R, Prisco D, Rostagno C, Boddi M, Gensini GF. Age-related changes in the haemostatic system. Int J Clin Lab Res. 2013; 23: 1–3.38
Ahlehoff O, Lindhardsen J, Gislason GH, Olesen JB, Charlott M, Skov L, Torp-Pedersen C, Hansen PR. Prognosis after percutaneous coronary intervention in patients with psoriasis: a cohort study using Danish nationwide registries. BMC Cardiovascular Disorders. 2012; 12: 79.113
Aibar МА, Laborda К, Conget F, Cornudella R. Hypercoagulability state and endotelial injury in stable chronic obstructive pulmonary disease patients. An Sist Sanit Navar. 2020; 33(1): 43- 50.138
Aliakhunova MYu, Nuriddinova SK. Hemorheological disorders in patients with rheumatoid arthritis in combination with arterial hypertension. Therapeutic Bulletin of Uzbekistan. 2014; 4: 157-158.60
Al-Lami F, Mousa A. Prevalence of undetected, untreated, and uncontrolled hypertension among attendants of primary health care centers in nasiriya city, Iraq. In: Proceedings of the 61st Annual Epidemic Intelligence Service Conference (EIS '12); April 2012; Atlanta, Ga, USA.122
Alyavi AL, Aliakhunova MYu, Nuritdinova SK. The state of platelet-vascular hemostasis in patients with rheumatoid arthritis and its use under the influence of low-intensity laser treatment. Therapeutic Bulletin of Uzbekistan. 2021; 2(3): 148.61
Alyavi AL, Sadikova GA, Nadjmitdinov ST. The effect of phototherapy on the cytological characteristics of platelets in patients with chronic obstructive pulmonary disease. Physiotherapy Balneology Rehabilitation. 2018; 5: 30-33.136
Alyavi Al, Tulyaganova DK. Features of endothelial dysfunction in patients with coronary heart disease. Therapeutic Bulletin of Uzbekistan. 2013; 4: 32.127
Alyavi AL, Tursunov RR, Aripov BS, Sabirjanova ZT. Features of the course of ischemic heart disease in patients with chronic obstructive pulmonary disease. 4th Congress of the Euro-Asian Respiratory Society and the 5th International Congress of Pulmonologists, 2018.108
Amidjanova HG, Kaurov BA. Aging, age-related diseases and some risk factors for cardiovascular diseases in elderly and senile people. Clinical Medicina. 2011; 3: 21-26.34
Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir. 2012; 166: 675-679.21
Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2020; 284: 835–842.130
Arlt AV, Ivashev MN, Savenko IA. The effect of nicotine on blood circulation in the brain. International Journal of Applied and Basic Research. 2013; 11: 90-91.47
Avina-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2018; 59: 1690–1697.66
Avina-Zubieta JA, Thomas J, Sadatsafavi M, et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012; 71: 1524–1529.64
Bagdonas E, Raudoniute J, Bruzauskaite I, Aldonyte R. Novel aspects of pathogenesis and regeneration mechanisms in COPD. Int J Chron Obstruct Pulmon Dis. 2015; 10: 995-1013.23
Balmes J, Becklake M, Blanc P et al. American Thoracic Society statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med. 2013; 67: 787-797.24
Barbar S, et al. A risk assessment model for the identifi cation of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thrombosis Haemostasis. 2020; 8(11): 2450–2457.100
Barbar S, et al. A risk assessment model for the identifi cation of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thrombosis Haemostasis. 2010; 8(11): 2450–2457.131
Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2000;343:269–80.1
Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010; 7(3):e1000220.10.18
Bergdahl IA, Toren K, Eriksson K et al. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur Respir J. 2014; 23: 402-406.25
Bezemer ID, Arellano AR, Tong CH, Rowland CM, Ireland HA, Bauer KA, Catanese J, Reitsma PH, Doggen CJ, Devlin JJ, Rosendaal FR, Bare LA. F9 Malmo, factor IX and deep vein thrombosis. Haematologica. 2019; 94: 693–699.41
Bezemer ID, Bare LA, Doggen CJ, Arellano AR, Tong C, Rowland CM, Catanese J, Young BA, Reitsma PH, Devlin JJ, Rosendaal FR. Gene variants associated with deep vein thrombosis. JAMA. 2018; 299: 1306–1314.40
Blanc PD, Torén K. Occupation in chronic obstructive pulmonary disease and chronic bronchitis: an update. Int J Tuberc Lung Dis. 2017; 11: 251-257.27
Bonar R, Favaloro EJ, Adcock DM. Quality in coagulation and haemostasis testing. Biochem Med. 2010; 20: 184–199.30
Borch KH, Nyegaard C, Hansen JB, Mathiesen EB, Njølstad I, Wilsgaard T, Brækkan SK. Joint Effects of Obesity and Body Height on the Risk of Venous Thromboembolism: The Tromsоn Study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2011; 31: 1439–1444.49
Breda L, Di Marzio D, Giannini C, Gaspari S, Nozzi M, Scarinci A, Chiarelli F, Mohn A. Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis, Clinical Research in Cardiology. 2013; 102(1) 63-71.114
Bucciarelli P, Mannucci PM. The hemostatic system through aging and menopause. Climacteric. 2019; 12(1): 47-51.32
Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL, Howard VJ, Lichtman JH, Lisabeth LD, Piña IL, Reeves MJ, Rexrode KM, Saposnik G, Singh V, Towfighi A, Vaccarino V, Walters MR on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Council for High Blood Pressure Research. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45: 1545–1588.43
Chang CL, Robinson SC, Mills GD, Sullivan GD, Karalus NC, McLachlan JD, Hancox RJ. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax. 2011; 66: 764–768.117
Charchar FJ, Bloomer LD, Barnes TA, Cowley MJ, Nelson CP, Wang Y, Denniff M, Debiec R, Christofidou P, Nankervis S, Dominiczak AF, Bani‐Mustafa A, Balmforth AJ, Hall AS, Erdmann J, Cambien F, Deloukas P, Hengstenberg C, Packard C, Schunkert H, et al. Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome. Lancet. 2012; 379: 915–922.39
Chereshneva VA, Litvickiy PF, Cigan VN. Clinical Pathophysiology. SpecLit. St. Petersburg, 2015.56
Chuchalin AG, Ceymakh IYa, Momot AP, Mamaev AN, Karbishev IA, Koatyuchenko GI. Changes in systemic inflammatory and hemostatic reactions in patients with exacerbation of chronic obstructive pulmonary disease with concomitant chronic heart failure and obesity. Pulmonology. 2014; 6: 25-31.88
Chuchalin AG. Chronic obstructive pulmonary disease and comorbidities. Pulmonology. 2018; 2: 5-14.6
Chuchalin AG. Global strategy for the diagnosis, treatment and prevention of chronic obstructive pulmonary disease (GOLD): Review. Atmosphere, Moscow 2007.9
Chuchalin AG. Respiratory Medicine. GEOTAR-Media, Moscow 2017.5
Cífková R. Epidemiology and risk of hypertension. Archives of Medical Science. 2009; 5(2A): 199–211.125
Corlateanu A, Covantev S, Mathioudakis AG, Botnaru V, Cazzola M, Siafakas N. Chronic obstructive pulmonary disease and stroke. COPD. 2018; 1080-1088.35
Dagenais GR, Lu J, Faxon DP, Bogaty P, Adler D, Fuentes F, Escobedo J, Krishnaswami A, Slater J, Frye RL. BARI 2D Study Group. Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial. J Am Coll Cardiol. 2013; 61: 702–711.101
de Lucas-Ramos P, Izquierdo-Alonso JL, Rodriguez-Gonzalez Moro JM, et al. Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). Int J Chron Obstruct Pulmon Dis. 2012; 7: 679–686.107
Di Fabio F, Obrand D, Satin R, et al. Intra-abdominal venous and arterial thromboembolism in inflammatory bowel disease. Dis Colon Rectum. 2019; 52: 336–342.71
Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med. 2012; 186: 155–161.55
Egorina EM, Sovershaev MA, Hansen John-Bjarnea. The role of tissue factor in systemic inflammatory response syndrome. Blood Coagulation & Fibrinolysis. 2011; 22(6): 451–456.57
Egorina EM, Sovershaev MA, Hansen John-Bjarnea. The role of protrombin factor in systemic inflammatory response syndrome. Blood Coagulation & Fibrinolysis. 2012; 22(6): 451– 456.118
Eisen A, Bhatt DL, Steg PG, et al. Angina and Future Cardiovascular Events in Stable Patients with Coronary Artery Disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Am Heart Assoc. 2016; 5(10): e004080.96
Eisner MD, Anthonisen N, Coultas D et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 182: 693 - 718.19
Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, Omachi TA. The influence of anxiety on health outcomes in COPD. Thorax. 2010; 65(3): 229–234.36
Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2018; 31: 204–212.93
Ferrari R, Abergel H, Ford I, Fox KM, Greenlaw N, Steg PG, Hu D, Tendera M, Tardif JC. CLARIFY Investigators. Gender and age related differences in clinical presentation and management of outpatients with stable coronary artery disease. Int J Cardiol. 2013; 167: 2938– 2943.97
Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis. 2019; 4: 337–349.95
Fishwick D, Sen D, Barber C, Bradshaw L, Robinson E, Sumner J. The COPD Standard Collaboration Group, Occupational chronic obstructive pulmonary disease: a standard of care. Occupational Medicine. 2015; 65: 270–282.28
Garcia-Rio F, Miravitlles M, Soriano JB, et al. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res. 2010; 11(1): 63.78
Garcia-Rio F, Miravitlles M, Soriano JB, et al. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res. 2010; 11(1): 63.111
Gargiulo P, Marsico F, Parente A, Paolillo S, Cecere M, Casaretti L, Pellegrino AM, Formisano T, Fabiani I, Soricelli A, Trimarco B, Perrone-Filardi P. Ischemic heart disease in systemic inflammatory diseases. An appraisal. International Journal of Cardiology. 2014; 170: 286- 290.115
Ginard KN. When one interferes with the other - comorbidity on the topic of the day. New Medicine of the Millennium. 2012; 22-24.91
Graham I, Atar D, Borch-Johnsen K, et al. European Atherosclerosis Society (EAS). Evropean guidelines on cardiovascular disease prevention in clinical practice. Evr J Cardiovasc Prev Rehab. 2017; 14: 1-113.84
Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010; 375: 657–663.69
Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med. 2013; 163: 2345–2353.132
Ha C, Magowan S, Accortt NA, et al. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. 2009; 104: 1445–1451.70
Harrison MT, Short P, Williamson PA, Singanayagam A, Chalmers JD, Schembri S. Thrombocytosis is associated with increased short- and long-term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy? Thorax. 2014; 69(7): 609-615.139
Hasan Z.N., Hussein M.Q., Haji G.F. Hypertension as a risk factor: is it different in ischemic stroke and acute myocardial infarction comparative cross-sectional study? Int J Hypertens. 2011; 2011: 701029.120
Hata J, Kiyohara Y. Epidemiology of stroke and coronary artery disease in Asia. Circ J. 2013; 77: 1923–1932.48
Ilkovich MM. COPD: a nosological form or a group of diseases? Atmosphere. 2012; 1(4): 27- 28.7
Kim SD, Baker P, DeLay J, Wood RD. Thrombomodulin Expression in Tissues from Dogs with Systemic Inflammatory Disease. Vet Pathol. 2016; 53(4): 797-802.74
Kimura Y, Pham NM, Yasuda K, Nanri A, Kurotani K, Kuwahara K, et al. Association of adulthood weight gain with circulating adipokine and insulin resistance in the Japanese population, Eur J Clin Nutr. 2015; 69(4): 462–466.53
Korreya LL, Lebedev TYu, Efremova OA, Proshaev KI, Litovchenko ES. The problem of polymorbidity with a combination of chronic obstructive pulmonary disease and some cardiovascular diseases. Scientific Bulletin of Belgorod State University. 2013; 21(4): 12- 17.109
Kretova YYu. Disorders of the hemostasis system at different age periods in patients with diabetes mellitus. Candidate of Science Dissertation. Tomsk, 2018.37
Kristensen SR, Johnsen SP, Dethlefsen C, Tjønneland A, Overvad K. Location Of Body Fat Affects Risk Of Blood Clots In Men, Women. ScienceDaily, 2019.50
Kuvaev VS, Bogdanova YuV, Selikhova MA, Kupaev VI, Davidkin IL. Microcirculatory disorders in patients with early stages of COPD. Practical Medicine. 2013; 5: 24-28.128
Laforest L, Roche N, Devouassoux G, et al. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study. Respir Med. 2016; 117: 33-39.15
Lakhan SE, Sapko MT. Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis. International Archives of Medicine. 2019; 2(1): 30.123
Lamprecht B, Mc Burnie MA, Vollmer WM et al. COPD in never smokers: results from the population - based burden of obstructive lung disease study. Chest. 2011; 139: 752 - 763.20
Li VV, Zadionchenko VS, Adasheva TV, Pavlov SV, Shakhray NB. Chronic obstructive pulmonary disease and arterial hypertension - metaphysics and dialectics. Cardiosomatics. 2013; 4(1): 5-10.94
Lijfering WM, Rosendaal FR, Cannegieter SC. Risk factors for venous thrombosis current understanding from an epidemiological point of view. Br J Haematol. 2010; 149: 824–33.105
Lip GY, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. Euro Heart Survey on atrial fibrillation. Chest. 2010; 137: 263–272.133
Lipinski S, Bremer L, Lammers T, Thieme F, Schreiber S, Rosenstiel P. Coagulation and inflammation. Molecular insights and diagnostic implications. Hamostaseologie. 2011; 31(2): 94–104.58
Luo W, Li M, Luo J, He Y. Clinical analysis of patients with autoimmune disease complicated by mesenteric vein thrombosis: a retrospective study in a hospital. Hepatogastroenterology. 2012; 59(115): 747-750.67
Mancia G, et al. ESH/ESC 2013 guidelines for the management of arterial hypertension. Systemic Hypertension. 2013; 10(3): 5–38.129
Mannino DM, Thorn D, Swensen A, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2018: 32: 962–969.54
Manuyakorn W, Mairiang D, Sirachainan N, Kadegasem P, Kamchaisatian W, Benjaponpitak S, Chuansumrit A. Blood Coagulation and Asthma Exacerbation in Children. Int Arch Allergy Immunol. 2016; 170: 75-83.73
Margetic S. Inflammation and haemostasis. Biochem Med (Zagreb). 2012; 22(1): 49–62.59
Mari D, Ogliari G, Castaldi D, Vitale G, Bollini EM, Lio D. Hemostasis and ageing. Immun Ageing. 2018; 5(12): 1742-4933.31
Marzano AV, Tedeschi A, Polloni I, Crosti C, Cugno M. Interactions between inflammation and coagulation in autoimmune and immune-mediated skin diseases. Curr Vasc Pharmacol. 2012; 10(5): 647-652.68
Mazitova NN. Occupational factors and chronic obstructive pulmonary disease: a meta- analysis. Fundamental Research. 2011; 9: 588 -592.26
McAllister DA, Maclay JD, Mills NL, Leitch A, Reid P, Carruthers R, O’Connor J, McAlpine L, Chalmers G, Newby DE, et al. Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD. Eur Respir J. 2012; 39: 1097–1103.116
Min K, Min J. Reduced Lung Function, C-Reactive Protein, and Increased Risk of Cardiovascular Mortality. Circ J. 2014; 78: 2309–2316.81
Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010; 121: 505–511.104
Naimova ShK, Akhmedova KJ. Coagulation hemostasis and risk factors for ischemic heart disease in patients with rheumatoid arthritis. Cardiology of Uzbekistan. 2016; 1(2): 159-160.62
O Donnell M, Xavier D, Liu L, Zhang H. Risk factors for ischaemic and intracerebral haemorragic stroke in 22 countries (the INTERSTROKE Study): a case-control study Reference // Lancet. -2010. -Vol.376. -P. 112-123.119
Obrezan AG, Kukol LV, Erdneev BA. Chronic obstructive disease and comorbid cardiovascular diseases in elderly and senile people: problems and treatment. Journal of St. Petersburg State University. 2010; 11(2): 51-66.14
Ørn S, Manhenke C, Ueland T, et al. C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. Euro Heart Journal. 2009; 30(10): 1180–1186.85
Park KL, Budaj A, Goldberg RJ, et al. Risk-Prerdiction Model for Ischemic Stroke in Patients Hospitalized with an acute coronary syndrome (from the Global registry of acute coronary events [GRACE]). Am J Cardiology. 2012; 110(5): 628–635.134
Patel ARC, Donaldson GC, Mackay AJ, Wedzicha JA, Hurst JR. The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD. Chest. 2012; 141: 851–857.110
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256–76.2
Pavasini R, Biscaglia S, d'Ascenzo F, Del Franco A, Contoli M, Zaraket F, Guerra F, Ferrari R, Campo G. Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis. COPD. 2016; 13(4): 509-514.140
Pedrinelli R, Ballo P, Fiorentini C, Denti S, Galderisi M, Ganau A, Germanò G, Innelli P, Paini A, Perlini S, Salvetti M, Zacà V. Hypertension and acute myocardial infarction: an overview. J Cardiovasc Med (Hagerstown). 2012; 13(3): 194-202.124
Perceva TA, Sanina NA. The severity of systemic inflammatory reactions in patients with chronic obstructive pulmonary disease. Pulmonology. 2013: 1: 38-41.79
Privalova EV. Morphological and functional features of the circulating pool of platelets and erythrocytes in smokers with chronic obstructive disease. Doctor of Medical Science Dissertation. St. Petersburg, 2010.46
Pumar MI, Gray CR, Walsh JR, Yang IA, Rolls TA, Ward DL. Anxiety and depression- Important psychological comorbidities of COPD. J Thorac Dis. 2014; 6(11): 1615-1631.22
Rabe KF, Wedzicha JA, Wouters EFM, et al. COPD and Comorbidity. Eur Respir Soc Monograph. 2013; 154.86
Reiner AP, Carty CL, Jenny NS, Nievergelt C, Cushman M, Stearns-Kurosawa DJ, Shinichiro Kurosawa S, Kuller LH, Lange LA. PROC, PROCR, and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study. J Thromb Haemost. 2008; 6: 1625–1632.33
Rembek M, Goch A, Goch J. The clinical course of acute ST-elevation myocardial infarction in patients with hypertension. Kardiologia Polska. 2010; 68(2): 157–163.121
Rodriguez LA, Wallander MA, Martin-Merino E, et al. Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study. Respir Med. 2010; 104: 1691–1699.11
Roger VL, Jacobsen SJ, Weston S, et al. Trends in the Incidence and Survival of Patients with Hospitalized Myocardial Infarction, Olmsted County, Minnesota, 1979 to 1994. Annals of Internal Medicine. 2002;136:341–8.3
Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003; 349: 2399–2406.65
Roy-O’Reilly M, McCullough LD. Sex Differences in Stroke: The Contribution of Coagulation. Exp Neurol. 2014; 259: 16–27.42
Roy-O’Reilly M, McCullough LD. Sex Differences in Stroke: The Contribution of Coagulation Exp Neurol. 2014; 259: 16–27.44
Ruf RR. The role of inflammation in the development of atherosclerosis and cardiovascular events. Siberian Medical Review. 2015; 6: 23-29.112
Rukavicina OA. Hematology. ASMOK, Moscow, 2015.29
Saldías PF, Díaz PO, Dreyse DJ, Gaggero BA, Sandoval AC, Lisboa BC. Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations. Rev Med Chil. 2012; 140(1): 10-18.75
Schiele F, Meneveau N, Seronde MF, et al. C-reactive protein improves risk prediction in patients with acute coronary syndromes. Euro Heart Journal. 2010; 31(3): 290–297.82
Schneider C, Bothner U, Jick SS, et al. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010; 25: 253–260.10
Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, Wolff JL, Boyd C. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross- sectional study using data from NHANES. BMC Pulm Med. 2012; 12(26): 1999-2008.92
Sehestedt T, Jeppesen J, Hansen TW, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Euro Heart Journal. 2010; 31(7): 883–891.83
Shirinskiy VS, Shirinskiy IV. Comorbid diseases - an urgent problem of clinical medicine. Siberian Medical Journal. 2014; 29(1) 7-9.89
Siddharth S, Singh H, Loftus Jr. EV, Pardi DS. Clinical Gastroenterology and Hepatology. 2014; 12: 382–393.72
Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107:1514–9.4
Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. A systematic review and metaanalysis. Ann Am Thorac Soc 2013; 10(2): 81–89.87
Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014; 9: 871–888.16
Sode BF, Dahl M, Nordestgaard BG. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. Eur Heart J. 2011; 32: 2365–2375.12
Steffen LM, Cushman M, Peacock JM, Heckbert SR, Jacobs Jr, Rosamond WD, et al. Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology. Journal of Thrombosis and Hemostasis. 2009; 7(5): 746–51.51
Steg PG, Greenlaw N, Tardif JC, Tendera M, Ford I, Kääb S, Abergel H, Fox KM, Ferrari R. CLARIFY Registry Investigators. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J. 2012; 33: 2831–2840.98
Steg PG, Greenlaw N, Tendera M, Tardif JC, Ferrari R, Al-Zaibag M, Dorian P, Hu D, Shalnova S, Sokn FJ, Ford I, Fox KM. Prospective Observational Longitudinal Registry of Patients With Stable Coronary Artery Disease (CLARIFY) Investigators. Prevalence of anginal
symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. JAMA Intern Med. 2014; 174:1651–1659.99
Sumerkina VA. State of hemostasis in men with overweight and metabolic syndrome. Clinical Laboratory Diagnostics. 2016; 9: 551.52
Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186(10): 982–988.76
Tsiligianni IG, Kosmas E, Van der Molen T, Tzanakis N. Managing comorbidity in COPD: a difficult task. Curr Drug Targets. 2013; 14(2): 158–176.17
Undas A, Kaczmarek P, Sladek K, Stepien E, Skucha W, Rzeszutko M, Gorkiewicz-Kot I, Tracz W. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment. Thromb Haemost. 2009; 102: 1176– 1182.103
Undas A, Kaczmarek P, Sladek K, Stepien E, Skucha W, Rzeszutko M, Gorkiewicz-Kot I, Tracz W. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment. Thromb Haemost. 2009; 102: 1176– 1182.106
Ungprasert P, Srivali N, Spanuchart I, Thongprayoon C, Knight EL. Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol. 2014; 33(3): 297-304.63
van Durme YM, Verhamme KM, Aarnoudse AJ, Van Pottelberge GR, Hofman A, Witteman JC, Joos GF, Brusselle GG, Stricker BH. C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009; 179(5): 375- 382.80
van Eeden SF, Sin DD. Chronic Obstructive Pulmonary disease: a chronic systemic inflammatory disease. Respiration. 2008; 75: 224-238.77
Vertkin AL, Skotnikov AS, Gubjokova OM. Comorbidity in chronic obstructive pulmonary disease: the role of chronic systemic inflammation and clinical and pharmacological niches of roflumilast. Attending Physician. 2013; 9: 143.90
Vinogradova NA. Hemorheological disorders and their correction in rheumatoid arthritis, Candidate of Medical Sciences Dissertation. Moscow, 2010.126
Vizel AA, Vizel IYu. Chronic obstructive pulmonary disease: inflammation as a key problem. Practical Medicine. 2009; 35: 22 - 24.8
Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all- cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 55: 1318–1327.102
Wolf PA, et al. Probability of stroke: From the Framingham Study. Stroke. 1991; 22: 312– 318.135
Yakovleva VG. Particularities of coagulation lanka damage to hemostasis in patients with chronic obstructive disease. Clinical Medicine. 2015; 3: 56-60.137
Yasamanova TI, Martinov MYu, Galkina SI. Impact of tobacco smoking on platelet and coagulation hemostasis. Issues of Naroclogy. 2009; 5: 23-29.45
Yin L, Lensmar C, Ingelsson E, et al. Differential association of chronic obstructive pulmonary disease with myocardial infarction and ischemic stroke in a nation-wide cohort. Int J Cardiol. 2014; 173: 601–603.13
